Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial

Am J Transplant. 2005 Jun;5(6):1574-5. doi: 10.1111/j.1600-6143.2005.00909.x.
No abstract available

Publication types

  • Guideline
  • Letter
  • Practice Guideline

MeSH terms

  • Cardiovascular Diseases / therapy
  • Clinical Trials as Topic
  • Fatty Acids, Monounsaturated / therapeutic use*
  • Fluvastatin
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / diagnosis*
  • Hyperlipidemias / therapy*
  • Indoles / therapeutic use*
  • Kidney Diseases / therapy
  • Kidney Transplantation*
  • Quality Control
  • Risk Factors

Substances

  • Fatty Acids, Monounsaturated
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Indoles
  • Fluvastatin